Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 372

1.

Resting-State fMRI Metrics in Acute Sport-Related Concussion and Their Association with Clinical Recovery: A Study from the NCAA-DOD CARE Consortium.

Meier TB, Giraldo-Chica M, España LY, Mayer AR, Harezlak J, Nencka AS, Wang Y, Koch KM, Wu YC, Saykin AJ, Giza CC, Goldman J, DiFiori JP, Guskiewicz KM, Mihalik JP, Brooks A, Broglio SP, McAllister T, McCrea MA.

J Neurotrauma. 2019 Sep 18. doi: 10.1089/neu.2019.6471. [Epub ahead of print]

PMID:
31407610
2.

3D-multi-spectral T2 mapping near metal implants.

Bhave S, Koff MF, Sivaram Kaushik S, Potter HG, Koch KM.

Magn Reson Med. 2019 Aug;82(2):614-621. doi: 10.1002/mrm.27744. Epub 2019 Mar 18.

PMID:
30883910
3.

Prevalence of Potentially Clinically Significant Magnetic Resonance Imaging Findings in Athletes with and without Sport-Related Concussion.

Klein AP, Tetzlaff JE, Bonis JM, Nelson LD, Mayer AR, Huber DL, Harezlak J, Mathews VP, Ulmer JL, Sinson GP, Nencka AS, Koch KM, Wu YC, Saykin AJ, DiFiori JP, Giza CC, Goldman J, Guskiewicz KM, Mihalik JP, Duma SM, Rowson S, Brooks A, Broglio SP, McAllister T, McCrea MA, Meier TB.

J Neurotrauma. 2019 Jun;36(11):1776-1785. doi: 10.1089/neu.2018.6055. Epub 2019 Feb 25.

PMID:
30618331
4.

Cerebral blood flow in acute concussion: preliminary ASL findings from the NCAA-DoD CARE consortium.

Wang Y, Nencka AS, Meier TB, Guskiewicz K, Mihalik JP, Alison Brooks M, Saykin AJ, Koch KM, Wu YC, Nelson LD, McAllister TW, Broglio SP, McCrea MA.

Brain Imaging Behav. 2019 Oct;13(5):1375-1385. doi: 10.1007/s11682-018-9946-5.

PMID:
30159767
5.

Quantitative Susceptibility Mapping after Sports-Related Concussion.

Koch KM, Meier TB, Karr R, Nencka AS, Muftuler LT, McCrea M.

AJNR Am J Neuroradiol. 2018 Jul;39(7):1215-1221. doi: 10.3174/ajnr.A5692. Epub 2018 Jun 7.

6.

The effects of lapatinib on CYP3A metabolism of midazolam in patients with advanced cancer.

Koch KM, Dees EC, Coker SA, Reddy NJ, Gainer SD, Arya N, Beelen AP, Lewis LD.

Cancer Chemother Pharmacol. 2017 Dec;80(6):1141-1146. doi: 10.1007/s00280-017-3470-y. Epub 2017 Nov 2.

PMID:
29098381
7.

Peripheral nerve diffusion tensor imaging: Overview, pitfalls, and future directions.

Jeon T, Fung MM, Koch KM, Tan ET, Sneag DB.

J Magn Reson Imaging. 2018 May;47(5):1171-1189. doi: 10.1002/jmri.25876. Epub 2017 Oct 30. Review.

PMID:
29083521
8.

Acute White-Matter Abnormalities in Sports-Related Concussion: A Diffusion Tensor Imaging Study from the NCAA-DoD CARE Consortium.

Mustafi SM, Harezlak J, Koch KM, Nencka AS, Meier TB, West JD, Giza CC, DiFiori JP, Guskiewicz KM, Mihalik JP, LaConte SM, Duma SM, Broglio SP, Saykin AJ, McCrea M, McAllister TW, Wu YC.

J Neurotrauma. 2018 Nov 15;35(22):2653-2664. doi: 10.1089/neu.2017.5158. Epub 2018 Aug 15.

9.

Stability of MRI metrics in the advanced research core of the NCAA-DoD concussion assessment, research and education (CARE) consortium.

Nencka AS, Meier TB, Wang Y, Muftuler LT, Wu YC, Saykin AJ, Harezlak J, Brooks MA, Giza CC, Difiori J, Guskiewicz KM, Mihalik JP, LaConte SM, Duma SM, Broglio S, McAllister T, McCrea MA, Koch KM.

Brain Imaging Behav. 2018 Aug;12(4):1121-1140. doi: 10.1007/s11682-017-9775-y.

10.

Fully phase-encoded MRI near metallic implants using ultrashort echo times and broadband excitation.

Wiens CN, Artz NS, Jang H, McMillan AB, Koch KM, Reeder SB.

Magn Reson Med. 2018 Apr;79(4):2156-2163. doi: 10.1002/mrm.26859. Epub 2017 Aug 21.

11.

Off-resonance based assessment of metallic wear debris near total hip arthroplasty.

Koch KM, Koff MF, Bauer TW, Shah PH, Nencka AS, Sivaram Kaushik S, Potter HG.

Magn Reson Med. 2018 Mar;79(3):1628-1637. doi: 10.1002/mrm.26807. Epub 2017 Jun 22.

12.

Multispectral diffusion-weighted imaging near metal implants.

Koch KM, Bhave S, Gaddipati A, Hargreaves BA, Gui D, Peters R, Bedi M, Mannem R, Kaushik SS.

Magn Reson Med. 2018 Feb;79(2):987-993. doi: 10.1002/mrm.26737. Epub 2017 May 3.

PMID:
28470795
13.

Imaging near orthopedic hardware.

Koff MF, Burge AJ, Koch KM, Potter HG.

J Magn Reson Imaging. 2017 Jul;46(1):24-39. doi: 10.1002/jmri.25577. Epub 2017 Feb 2. Review.

14.

Metallic implant geometry and susceptibility estimation using multispectral B0 field maps.

Shi X, Yoon D, Koch KM, Hargreaves BA.

Magn Reson Med. 2017 Jun;77(6):2402-2413. doi: 10.1002/mrm.26313. Epub 2016 Jul 6.

15.

A Phase II Biomarker-Embedded Study of Lapatinib plus Capecitabine as First-line Therapy in Patients with Advanced or Metastatic Gastric Cancer.

LaBonte MJ, Yang D, Zhang W, Wilson PM, Nagarwala YM, Koch KM, Briner C, Kaneko T, Rha SY, Gladkov O, Urba SG, Sakaeva D, Pishvaian MJ, Hsieh RK, Lee WP, Lenz HJ.

Mol Cancer Ther. 2016 Sep;15(9):2251-8. doi: 10.1158/1535-7163.MCT-15-0908. Epub 2016 Jun 20.

16.

Quantifying metal-induced susceptibility artifacts of the instrumented spine at 1.5T using fast-spin echo and 3D-multispectral MRI.

Kaushik SS, Karr R, Runquist M, Marszalkowski C, Sharma A, Rand SD, Maiman D, Koch KM.

J Magn Reson Imaging. 2017 Jan;45(1):51-58. doi: 10.1002/jmri.25321. Epub 2016 May 26.

PMID:
27227824
17.

Effect of lapatinib on oral digoxin absorption in patients.

Koch KM, Smith DA, Botbyl J, Arya N, Briley LP, Cartee L, White JH, Beyer J, Dar MM, Chung HC, Chu Q, Bang YJ.

Clin Pharmacol Drug Dev. 2015 Nov;4(6):449-53. doi: 10.1002/cpdd.189. Epub 2015 Jun 2.

PMID:
27137717
18.

External calibration of the spectral coverage for three-dimensional multispectral MRI.

Kaushik SS, Marszalkowski C, Koch KM.

Magn Reson Med. 2016 Nov;76(5):1494-1503. doi: 10.1002/mrm.26065. Epub 2015 Nov 24.

PMID:
26745139
19.

Lapatinib Plasma and Tumor Concentrations and Effects on HER Receptor Phosphorylation in Tumor.

Spector NL, Robertson FC, Bacus S, Blackwell K, Smith DA, Glenn K, Cartee L, Harris J, Kimbrough CL, Gittelman M, Avisar E, Beitsch P, Koch KM.

PLoS One. 2015 Nov 16;10(11):e0142845. doi: 10.1371/journal.pone.0142845. eCollection 2015.

20.

Managing Chronic Pain in Children and Adolescents: A Clinical Review.

Landry BW, Fischer PR, Driscoll SW, Koch KM, Harbeck-Weber C, Mack KJ, Wilder RT, Bauer BA, Brandenburg JE.

PM R. 2015 Nov;7(11 Suppl):S295-S315. doi: 10.1016/j.pmrj.2015.09.006. Review.

PMID:
26568508
21.

Wavelet Domain Radiofrequency Pulse Design Applied to Magnetic Resonance Imaging.

Huettner AM, Mickevicius NJ, Ersoz A, Koch KM, Muftuler LT, Nencka AS.

PLoS One. 2015 Oct 30;10(10):e0141151. doi: 10.1371/journal.pone.0141151. eCollection 2015.

22.

Cerebral Blood Flow Alterations in Acute Sport-Related Concussion.

Wang Y, Nelson LD, LaRoche AA, Pfaller AY, Nencka AS, Koch KM, McCrea MA.

J Neurotrauma. 2016 Jul 1;33(13):1227-36. doi: 10.1089/neu.2015.4072. Epub 2015 Nov 12.

23.

Characterization of energy and performance of swine fed a novel corn-soybean extruded product.

Koch KM, Thaler RC, Baidoo SK, Levesque CL, Bott RC.

J Anim Sci Biotechnol. 2015 Apr 16;6(1):17. doi: 10.1186/s40104-015-0011-6. eCollection 2015.

24.

Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients.

Koch KM, Ferron-Brady G, Lemmon C, Cartee L, Hollyfield H, D'Amelio AM Jr, Piepszak A, Swaby RF, Curran D, Arya N.

Clin Pharmacol Drug Dev. 2015 May-Jun;4(3):203-9. doi: 10.1002/cpdd.139. Epub 2014 Oct 27.

PMID:
27140800
25.

Metal artefact suppression at 3 T MRI: comparison of MAVRIC-SL with conventional fast spin echo sequences in patients with Hip joint arthroplasty.

Kretzschmar M, Nardo L, Han MM, Heilmeier U, Sam C, Joseph GB, Koch KM, Krug R, Link TM.

Eur Radiol. 2015 Aug;25(8):2403-11. doi: 10.1007/s00330-015-3628-0. Epub 2015 Feb 14.

26.

Bone adaptation to cyclic loading in murine caudal vertebrae is maintained with age and directly correlated to the local micromechanical environment.

Lambers FM, Kuhn G, Weigt C, Koch KM, Schulte FA, Müller R.

J Biomech. 2015 Apr 13;48(6):1179-87. doi: 10.1016/j.jbiomech.2014.11.020. Epub 2014 Dec 8.

PMID:
25543278
27.

Metal artifact reduction with MAVRIC SL at 3-T MRI in patients with hip arthroplasty.

Choi SJ, Koch KM, Hargreaves BA, Stevens KJ, Gold GE.

AJR Am J Roentgenol. 2015 Jan;204(1):140-7. doi: 10.2214/AJR.13.11785.

28.

MR imaging near metallic implants using MAVRIC SL: initial clinical experience at 3T.

Gutierrez LB, Do BH, Gold GE, Hargreaves BA, Koch KM, Worters PW, Stevens KJ.

Acad Radiol. 2015 Mar;22(3):370-9. doi: 10.1016/j.acra.2014.09.010. Epub 2014 Nov 27.

29.

Flexible longitudinal magnetization contrast in spectrally overlapped 3D-MSI metal artifact reduction sequences: Technical considerations and clinical impact.

Koch KM, Koff MF, Shah PH, Kanwischer A, Gui D, Potter HG.

Magn Reson Med. 2015 Nov;74(5):1349-55. doi: 10.1002/mrm.25518. Epub 2014 Nov 3.

PMID:
25365957
30.

A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study).

Fumoleau P, Koch KM, Brain E, Lokiec F, Rezai K, Awada A, Hayward L, Werutsky G, Bogaerts J, Marréaud S, Cardoso F.

Breast. 2014 Oct;23(5):663-9. doi: 10.1016/j.breast.2014.07.003. Epub 2014 Jul 24.

31.

Phase I dose-escalation study of 5-day intermittent oral lapatinib therapy in patients with human epidermal growth factor receptor 2-overexpressing breast cancer.

Chien AJ, Munster PN, Melisko ME, Rugo HS, Park JW, Goga A, Auerback G, Khanafshar E, Ordovas K, Koch KM, Moasser MM.

J Clin Oncol. 2014 May 10;32(14):1472-9. doi: 10.1200/JCO.2013.52.1161. Epub 2014 Apr 7.

32.

Accelerating sequences in the presence of metal by exploiting the spatial distribution of off-resonance.

Smith MR, Artz NS, Koch KM, Samsonov A, Reeder SB.

Magn Reson Med. 2014 Dec;72(6):1658-67. doi: 10.1002/mrm.25087. Epub 2014 Jan 15.

33.

Effects of low-fat and high-fat meals on steady-state pharmacokinetics of lapatinib in patients with advanced solid tumours.

Devriese LA, Koch KM, Mergui-Roelvink M, Matthys GM, Ma WW, Robidoux A, Stephenson JJ, Chu QS, Orford KW, Cartee L, Botbyl J, Arya N, Schellens JH.

Invest New Drugs. 2014 Jun;32(3):481-8. doi: 10.1007/s10637-013-0055-4. Epub 2013 Dec 19.

PMID:
24346280
34.

Effects of Esomeprazole on the Pharmacokinetics of Lapatinib in Breast Cancer Patients.

Koch KM, Im YH, Kim SB, Urruticoechea Ribate A, Stephenson J, Botbyl J, Cartee L, Holshouser J, Ridgway D.

Clin Pharmacol Drug Dev. 2013 Oct;2(4):336-41. doi: 10.1002/cpdd.45. Epub 2013 Jul 10.

PMID:
27121938
35.

Optimally tolerated dose of lapatinib in combination with docetaxel plus trastuzumab in first-line treatment of HER2-positive metastatic breast cancer.

Crown J, Kennedy MJ, Tresca P, Marty M, Espie M, Burris HA, DeSilvio M, Lau MR, Kothari D, Koch KM, Diéras V.

Ann Oncol. 2013 Aug;24(8):2005-11. doi: 10.1093/annonc/mdt222.

PMID:
23878115
36.

Imaging near metal: The impact of extreme static local field gradients on frequency encoding processes.

Koch KM, King KF, Carl M, Hargreaves BA.

Magn Reson Med. 2014 Jun;71(6):2024-34. doi: 10.1002/mrm.24862. Epub 2013 Jul 10.

37.

A dose-escalation study of recombinant human interleukin-18 in combination with rituximab in patients with non-Hodgkin lymphoma.

Robertson MJ, Kline J, Struemper H, Koch KM, Bauman JW, Gardner OS, Murray SC, Germaschewski F, Weisenbach J, Jonak Z, Toso JF.

J Immunother. 2013 Jul-Aug;36(6):331-41. doi: 10.1097/CJI.0b013e31829d7e2e.

38.

Magnetic resonance imaging findings in symptomatic versus asymptomatic subjects following metal-on-metal hip resurfacing arthroplasty.

Nawabi DH, Hayter CL, Su EP, Koff MF, Perino G, Gold SL, Koch KM, Potter HG.

J Bone Joint Surg Am. 2013 May 15;95(10):895-902. doi: 10.2106/JBJS.K.01476.

PMID:
23677356
39.

Quantifying image distortion of orthopedic materials in magnetic resonance imaging.

Koff MF, Shah P, Koch KM, Potter HG.

J Magn Reson Imaging. 2013 Sep;38(3):610-8. doi: 10.1002/jmri.23991. Epub 2013 Jan 4.

PMID:
23292702
40.
41.

An European Organisation for Research and Treatment of Cancer phase I study of lapatinib and docetaxel as neoadjuvant treatment for human epidermal growth factor receptor 2 (HER2) positive locally-advanced/inflammatory or large operable breast cancer.

Bonnefoi H, Zaman K, Debled M, Fiche M, Fournier M, Nobahar M, Pierga JY, Koch KM, Bartlett J, Zimmer A, Marreaud S, Bogaerts J, Cameron D.

Eur J Cancer. 2013 Jan;49(2):281-9. doi: 10.1016/j.ejca.2012.08.006. Epub 2012 Sep 18.

PMID:
22999386
42.

Subject-specific models of susceptibility-induced B0 field variations in breast MRI.

Jordan CD, Daniel BL, Koch KM, Yu H, Conolly S, Hargreaves BA.

J Magn Reson Imaging. 2013 Jan;37(1):227-32. doi: 10.1002/jmri.23762. Epub 2012 Aug 3.

43.

Phase II trial of lapatinib in adult and pediatric patients with neurofibromatosis type 2 and progressive vestibular schwannomas.

Karajannis MA, Legault G, Hagiwara M, Ballas MS, Brown K, Nusbaum AO, Hochman T, Goldberg JD, Koch KM, Golfinos JG, Roland JT, Allen JC.

Neuro Oncol. 2012 Sep;14(9):1163-70. doi: 10.1093/neuonc/nos146. Epub 2012 Jul 27.

44.

Compressed-sensing multispectral imaging of the postoperative spine.

Worters PW, Sung K, Stevens KJ, Koch KM, Hargreaves BA.

J Magn Reson Imaging. 2013 Jan;37(1):243-8. doi: 10.1002/jmri.23750. Epub 2012 Jul 12.

45.

Metal-induced artifacts in MRI.

Hargreaves BA, Worters PW, Pauly KB, Pauly JM, Koch KM, Gold GE.

AJR Am J Roentgenol. 2011 Sep;197(3):547-55. doi: 10.2214/AJR.11.7364. Review.

46.

MRI after arthroplasty: comparison of MAVRIC and conventional fast spin-echo techniques.

Hayter CL, Koff MF, Shah P, Koch KM, Miller TT, Potter HG.

AJR Am J Roentgenol. 2011 Sep;197(3):W405-11. doi: 10.2214/AJR.11.6659.

PMID:
21862766
47.

New MR imaging methods for metallic implants in the knee: artifact correction and clinical impact.

Chen CA, Chen W, Goodman SB, Hargreaves BA, Koch KM, Lu W, Brau AC, Draper CE, Delp SL, Gold GE.

J Magn Reson Imaging. 2011 May;33(5):1121-7. doi: 10.1002/jmri.22534.

48.

Imaging near metal with a MAVRIC-SEMAC hybrid.

Koch KM, Brau AC, Chen W, Gold GE, Hargreaves BA, Koff M, McKinnon GC, Potter HG, King KF.

Magn Reson Med. 2011 Jan;65(1):71-82. doi: 10.1002/mrm.22523.

49.

Magnetic resonance imaging near metal implants.

Koch KM, Hargreaves BA, Pauly KB, Chen W, Gold GE, King KF.

J Magn Reson Imaging. 2010 Oct;32(4):773-87. doi: 10.1002/jmri.22313. Review.

PMID:
20882607
50.

Resiliency and vulnerability in the HER2-HER3 tumorigenic driver.

Amin DN, Sergina N, Ahuja D, McMahon M, Blair JA, Wang D, Hann B, Koch KM, Shokat KM, Moasser MM.

Sci Transl Med. 2010 Jan 27;2(16):16ra7. doi: 10.1126/scitranslmed.3000389.

Supplemental Content

Support Center